Skip to main content

Measuring What Matters 2023

5 Presentations 0 Sections

Measuring What Matters in Oncology:
Translating research into clinical practice using clinical registries

Cancer is a leading cause of morbidity and mortality globally. Clinical (including quality) registries are recognized as important tools for monitoring and evaluating quality of care by measuring variation from what is considered evidence-based, optimal practice (often defined a priori by a consensus process involving clinical experts and consumers). The complementary use of clinical and patient-reported data provides a comprehensive assessment of the impact of compliance, and through insights into variations between institutions (through benchmarking performance), registries provide invaluable opportunities for implementation research.

The 2023 Measuring What Matters virtual symposium focuses on clinical (quality) registries in oncology and explores the role of patient-reported outcomes measures (PROMs) as part of these registries.

Symposium Committee Co-Chairs

Ashika Maharaj, BPharm PhD
Monash University (Affiliate), Australia
Delft University of Technology (TU Delft), The Netherlands

Liane Ioannou, BSc(Hons) PhD
Victorian Cancer Agency Mid-Career Research Fellow,
Cancer Research Program
Victoria, Australia

Together With:

ISOQOL members receive a discounted rate. To view membership rates, click  here.

Presentation Icon

Session 2: Q&A

Presentation: Kelly de Ligt, PhD, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Netherlands, Roxanne E. Jensen, PhD National Cancer Institute, Maryland, United States, Bellinda King-Kallimanis, PhD, LUNGevity Foundation, United States, Ashika Maharaj, BPharm PhD, Monash University (Affiliate), Australia, Delft University of Technology (TU Delft), The Netherlands, Liane Ioannou, BSc(Hons) PhD, Victorian Cancer Agency Mid-Career Research Fellow, Cancer Research Program, Victoria, Australia, 18 min 21 sec